Nuzenio

Mediar

Mediar news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Employee Wellness Initiatives Highlight Mediar Therapeutics’ Internal Culture - TipRanksTipRanks · Sat, 08 Aug 2026 04:46:30 GMTJapan's Ono Pharmaceutical Funds Fibrosis Discovery After Lilly's $99M Bet on Same Biotech - Tech TimesTech Times · Fri, 07 Aug 2026 17:47:39 GMTMediar Therapeutics enters option deal with Ono Pharma - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 10:18:54 GMTMediar and Ono to develop fibro-inflammatory treatments - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 07 Aug 2026 08:48:19 GMTMediar and Ono to Develop Novel Treatments Targeting Fibro-Inflammatory Diseases - Contract PharmaContract Pharma · Thu, 06 Aug 2026 20:17:24 GMTMediar partners with Ono Pharma on fibro-inflammatory discovery - AllSciAllSci · Thu, 06 Aug 2026 16:25:44 GMTMediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases - PR NewswirePR Newswire · Thu, 06 Aug 2026 11:00:00 GMTMediar Therapeutics Enters Antibody Collaboration with Ono Pharma for Fibro-Inflammatory Diseases - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 04:46:30 GMTEmployee Wellness Initiatives Highlight Mediar Therapeutics’ Internal Culture - TipRanks
Fri, 07 Aug 2026 17:47:39 GMTJapan's Ono Pharmaceutical Funds Fibrosis Discovery After Lilly's $99M Bet on Same Biotech - Tech Times
Fri, 07 Aug 2026 10:18:54 GMTMediar Therapeutics enters option deal with Ono Pharma - The Pharma Letter
Fri, 07 Aug 2026 08:48:19 GMTMediar and Ono to develop fibro-inflammatory treatments - Pharmaceutical Technology
Thu, 06 Aug 2026 20:17:24 GMTMediar and Ono to Develop Novel Treatments Targeting Fibro-Inflammatory Diseases - Contract Pharma
Thu, 06 Aug 2026 16:25:44 GMTMediar partners with Ono Pharma on fibro-inflammatory discovery - AllSci

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mediar.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.